Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter (original) (raw)
Adkins EM, Barker EL, Blakely RD (2001) Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Mol Pharmacol 59:514–523 CASPubMed Google Scholar
Angrist B, Gershon S, Sathananthan G, Walker RW, Lopez-Ramos B, Mandel LR, Vandenheuvel WJ (1976) Dimethyltryptamine levels in blood of schizophrenic patients and control subjects. Psychopharmacology (Berl) 47:29–32 ArticleCAS Google Scholar
Axelrod J (1961) Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science 134:343 ArticleCASPubMed Google Scholar
Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399–410 ArticleCASPubMed Google Scholar
Barker SA, Beaton JM, Christian ST, Monti JA, Morris PE (1982) Comparison of the brain levels of _N,N_-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-_N,N_-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect. Biochem Pharmacol 31:2513–2516 ArticleCASPubMed Google Scholar
Barker EL, Kimmel HL, Blakely RD (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacol 46:799–807 CASPubMed Google Scholar
Barker EL, Moore KR, Rakhshan F, Blakely RD (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705–4717 CASPubMed Google Scholar
Berge OG, Chacho D, Hole K (1983) Inhibitory effect of 5-methoxy-N,_N_-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine. Eur J Pharmacol 90:293–296 ArticleCASPubMed Google Scholar
Brutcher JF, Vanderwerff W (1958) Concerning a preparation of tryptamine. J Org Chem 23:146–147 ArticleCAS Google Scholar
Burchett SA, Hicks TP (2006) The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79:223–246 ArticleCASPubMed Google Scholar
Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC (1999) Pharmacokinetics of hoasca alkaloids in healthy humans. J Ethnopharmacol 65:243–256 ArticleCASPubMed Google Scholar
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (k1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108 ArticleCASPubMed Google Scholar
Corbett L, Christian ST, Morin RD, Benington F, Smythies JR (1978) Hallucinogenic _N_-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations. Br J Psychiatry 132:139–144 ArticleCASPubMed Google Scholar
Cozzi NV, Foley KF (2002) Rapid and efficient method for suspending cells for neurotransmitter uptake assays. Biotechniques 32:486–492 CASPubMed Google Scholar
Crespi D, Mennini T, Gobbi M (1997) Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, _p_-chloroamphetamine and (+)-fenfluramine. Br J Pharmacol 121:1735–1743 ArticleCASPubMed Google Scholar
Deliganis AV, Pierce PA, Peroutka SJ (1991) Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. Biochem Pharmacol 41:1739–1744 ArticleCASPubMed Google Scholar
Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008) Hallucinogen-like effects of N,_N_-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacol Biochem Behav 88:358–365 ArticleCASPubMed Google Scholar
Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N,_N_-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323:934–937 ArticleCASPubMed Google Scholar
Franzen F, Gross H (1965) Tryptamine, N,_N_-dimethyltryptamine, N,_N_-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine. Nature 206:1052 ArticleCASPubMed Google Scholar
Glennon RA, Liebowitz SM, Mack EC (1978) Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,_N_-dimethyltryptamine analogues. J Med Chem 21:822–825 ArticleCASPubMed Google Scholar
Hayashi T, Su TP (2003) Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108–15 cells. J Pharmacol Exp Ther 306:726–733 ArticleCASPubMed Google Scholar
Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131:596–610 ArticleCASPubMed Google Scholar
Jacob MS, Presti DE (2005) Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Med Hypotheses 64:930–937 ArticleCASPubMed Google Scholar
Lupardus PJ, Wilke RA, Aydar E, Palmer CP, Chen Y, Ruoho AE, Jackson MB (2000) Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 526(Pt 3):527–539 ArticleCASPubMed Google Scholar
Mandell AJ, Morgan M (1971) Indole(ethyl)amine _N_-methyltransferase in human brain. Nat New Biol 230:85–87 CASPubMed Google Scholar
Marcusson JO, Bergstrom M, Eriksson K, Ross SB (1988) Characterization of [3H]paroxetine binding in rat brain. J Neurochem 50:1783–1790 ArticleCASPubMed Google Scholar
Mavlyutov TA, Ruoho AE (2007) Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells. J Mol Signal 2:8 ArticlePubMed Google Scholar
McKenna DJ, Repke DB, Lo L, Peroutka SJ (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29:193–198 ArticleCASPubMed Google Scholar
McKenna DJ, Guan XM, Shulgin AT (1991) 3, 4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of [3H]dopamine and [3H]5-hydroxytryptamine. Pharmacol Biochem Behav 38:505–512 ArticleCASPubMed Google Scholar
Morgan M, Mandell AJ (1969) Indole(ethyl)amine _N_-methyltransferase in the brain. Science 165:492–493 ArticleCASPubMed Google Scholar
Nagai F, Nonaka R, Satoh Hisashi Kamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132–137 ArticleCASPubMed Google Scholar
Nelson PJ, Rudnick G (1979) Coupling between platelet 5-hydroxytryptamine and potassium transport. J Biol Chem 254:10084–10089 CASPubMed Google Scholar
Olivier B, Soudijn W, van Wijngaarden I (2000) Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Prog Drug Res 54:59–119 CASPubMed Google Scholar
Oon MC, Murray RM, Rodnight R, Murphy MP, Birley JL (1977) Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects. Psychopharmacology (Berl) 54:171–175 ArticleCAS Google Scholar
Pochettino ML, Cortella AR, Ruiz M (1999) Hallucinogenic snuff from northwestern Argentina: microscopical identification of Anadenantheracolubrina var Cebil (fabaceae) in powdered archaeological material. Econ Bot 53:127–132 Google Scholar
Reimann W, Schneider F (1993) The serotonin receptor agonist 5-methoxy-N,_N_-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity. Gen Pharmacol 24:449–453 CASPubMed Google Scholar
Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 306:73–83 ArticleCASPubMed Google Scholar
Rothman RB, Becketts KM, Radesca LR, de Costa BR, Rice KC, Carroll FI, Dersch CM (1993) Studies of the biogenic amine transporters II A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci 53:PL267–PL272 Google Scholar
Rothman RB, Ayestas MA, Dersch CM, Baumann MH (1999) Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 100:869–875 CASPubMed Google Scholar
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41 ArticleCASPubMed Google Scholar
Saavedra JM, Axelrod J (1972) Psychotomimetic _N_-methylated tryptamines: formation in brain in vivo and in vitro. Science 175:1365–1366 ArticleCASPubMed Google Scholar
Sangiah S, Gomez MV, Domino EF (1979) Accumulation of N,_N_-dimethyltryptamine in rat brain cortical slices. Biol Psychiatry 14:925–936 CASPubMed Google Scholar
Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115–121 ArticleCASPubMed Google Scholar
Shulgin AT and Shulgin A (1997) TIHKAL: the continuation. Transform Press, Berkeley, CA 94712
Shulgin AT, Carter MF (1980) N,_N_-diisopropyltryptamine (DIPT) and 5-methoxy-N,_N_-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. Commun Psychopharmacol 4:363–369 CASPubMed Google Scholar
Sievert MK, Thiriot DS, Edwards RH, Ruoho AE (1998) High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells. Biochem J 330(Pt 2):959–966 CASPubMed Google Scholar
Sitaram BR, Lockett L, Talomsin R, Blackman GL, McLeod WR (1987) In vivo metabolism of 5-methoxy-N,_N_-dimethyltryptamine and N,_N_-dimethyltryptamine in the rat. Biochem Pharmacol 36:1509–1512 ArticleCASPubMed Google Scholar
Smith TE, Weissbach H, Udenfriend S (1962) Studies on the mechanism of action of monoamine oxidase: metabolism of N,_N_-dimethyltryptamine and N,_N_-dimethyltryptamine-_N_-oxide. Biochemistry 1:137–143 ArticleCASPubMed Google Scholar
Smythies JR, Morin RD, Brown GB (1979) Identification of dimethyltryptamine and _O_-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry. Biol Psychiatry 14:549–556 CASPubMed Google Scholar
Speeter ME, Anthony WC (1954) The action of oxalyl chloride on indoles: a new approach to tryptamines. J Am Chem Soc 76:6208–6210 ArticleCAS Google Scholar
Strassman RJ (2001) DMT: the spirit molecule: a doctor’s revolutionary research into the biology of near-death and mystical experiences. Park Street Press, Rochester, VT Google Scholar
Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose–response study of N,_N_-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98–108 CASPubMed Google Scholar
Su T-P, Hayashi T, Vaupel DB (2009) When the endogenous hallucinogenic trace amine _N,N_-dimethyltryptamine meets the sigma-1 receptor. Sci Signal 2: pe12
Takahashi T, Takahashi K, Ido T, Yanai K, Iwata R, Ishiwata K, Nozoe S (1985) 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions. Int J Appl Radiat Isot 36:965–969 ArticleCASPubMed Google Scholar
Talvenheimo J, Nelson PJ, Rudnick G (1979) Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport. J Biol Chem 254:4631–4635 CASPubMed Google Scholar
Tanimukai H, Ginther R, Spaide J, Bueno JR, Himwich HE (1970) Detection of psychotomimetic N,_N_-dimethylated indoleamines in the urine of four schizophrenic patients. Br J Psychiatry 117:421–430 ArticleCASPubMed Google Scholar
Thiriot DS, Ruoho AE (2001) Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2). Cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport. J Biol Chem 276:27304–27315 ArticleCASPubMed Google Scholar
Thompson MA, Moon E, Kim UJ, Xu J, Siciliano MJ, Weinshilboum RM (1999) Human indolethylamine _N_-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics 61:285–297 ArticleCASPubMed Google Scholar
Weissman AD, Su TP, Hedreen JC, London ED (1988) Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther 247:29–33 CASPubMed Google Scholar
Whipple MR, Reinecke MG, Gage FH (1983) Inhibition of synaptosomal neurotransmitter uptake by hallucinogens. J Neurochem 40:1185–1188 ArticleCASPubMed Google Scholar
Wyatt RJ, Saavedra JM, Axelrod J (1973) A dimethyltryptamine-forming enzyme in human blood. Am J Psychiatry 130:754–760 CASPubMed Google Scholar
Yanai K, Ido T, Ishiwata K, Hatazawa J, Takahashi T, Iwata R, Matsuzawa T (1986) In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,_N_-[11C]dimethyltryptamine. Eur J Nucl Med 12:141–146 CASPubMed Google Scholar
Yritia M, Riba J, Ortuno J, Ramirez A, Castillo A, Alfaro Y, de la Torre R, Barbanoj MJ (2002) Determination of N,_N_-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of ayahuasca. J Chromatogr B Analyt Technol Biomed Life Sci 779:271–281 ArticleCASPubMed Google Scholar
Zhang H, Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87:2867–2879 CASPubMed Google Scholar